IRMD (IRADIMED) Net Profit

Corporate emblem and logo of iradimed.com (IRMD)

IRADIMED CORPORATION (IRMD) relies on precision automation and computer vision quality control for the production of MRI infusion systems. Its monopoly position enables the sale of unique monitors with high markups, while the distribution of consumables ensures stable profitability. Technological superiority and patents create an insurmountable barrier for other players. The current indicator is 0.02, which is confirmed by the price action chronology of the company.

IRMD: IRADIMED CORPORATION Net Profit 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for IRADIMED (IRMD)

- current quotes and average value forecast:
Market Chart IRADIMED Inc.|IRMD - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization IRADIMED Inc.|IRMD - Total Company Value
- book capitalization data:
Net Assets per Single Share IRADIMED|IRMD - Book Capitalization|Market Capitalization to Book Value iradimed.com|IRMD - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity IRADIMED CORPORATION|IRMD - Long-Term Debt to Capital|Current Liabilities to Capital IRADIMED Corp|IRMD - Company Aggregate Debts|Debt to Book Value Ratio IRADIMED Inc.|IRMD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings IRADIMED|Quick Liquidity Indicator iradimed.com
- earnings and valuation multiples information:
IRMD - Net Profit
Fundamental valuation:IRADIMED Inc.
Product sample of IRADIMED CORPORATION

Investors must distinguish long-term business sustainability from short-term market volatility. This indicator tracks daily net income, enabling the identification of anomalous one-off transactions and the actual profitability trend. By analyzing the company's profit dynamics, one can assess the efficiency of asset capitalization. The stability of these metrics is supported by the monopoly position of IRADIMED CORPORATION (IRMD) in the specialized non-ferrous MRI pump segment. Patent protection for such devices guarantees a steady stream of profit.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income Embecta EMBC|TNDM - Net Income|Axogen Corp - Net Profit|Company Net Income SI-BONE Medical|OFIX: Net Profit|Company Profit BVS|KIDS (OrthoPediatrics Corp) - Net Profit|Treace Medical Concepts Inc (TMCI) - Net Financial Result|Net Profit SRTA|Net Income Carlsmed Medical CARL|Net Profit RXST (RxSight, Inc.)|Net Profit ClearPoint Neuro Inc. CLPT|STXS - Company Net Income|STIM: Company Net Income|SGHT (Sight Sciences, Inc) - Net Income|Orchestra BioMed Inc. - Final Profit|ANIK (Anika Therapeutics Inc.) - Net Profit|Company Net Income inspiremd.com NSPR|Company Net Income Jin Medical International (ZJYL)|vivani.com (VANI) - Annual Net Income|Xtant Medical - Net Income|Net Profit NeuroOne Medical Technologies Corp. NMTC|Modular Med - Net Profit|Net Financial Result myomo.com MYO|Envoy Medical (COCH) - Company Net Income|Profit After Tax VVOS (Vivos Therapeutics Inc.)|Company Net Income enVVeno|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOL: Net Profit|DYNT - Net Financial Result|Company Net Income Paragon 28 Inc.|INVO: Final Profit